MedTrace Logo

Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage

NCT04512859 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2020-09-09

No results posted yet for this study

Summary

To investigate whether the stellate ganglion block is helpful in relieving cerebral vasospasm during aneurysmal coil embolism surgery. The effect was assessed by Transcranial Doppler (TCD).

Conditions

  • Subarachnoid Hemorrhage, Aneurysmal
  • Cerebral Vasospasm

Interventions

PROCEDURE

Stellate Ganglion Block

Stellate ganglion block under ultra-guide will be administered using 0.25% ropivacaine 10mL

PROCEDURE

Placebo

Stellate ganglion block under ultra-guide will be administered using 0.9% saline 10mL

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2022-12-31
Completion
2022-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04512859 on ClinicalTrials.gov